S11: carcinomas & cysts Flashcards
Describe the difference in location of a renal cell carcinoma vs transitional cell carcinoma
Renal cell carcinoma – presents in the parenchyma of the kidney
Transitional cell carcinoma – from calyx to the bladder
Describe the epidemiology of RCC
Arise from tubular epithelium
Rare in children, peak incidence in 60–70-year-olds, more common in males
Risk factors: dialysis, smoking & obesity
Describe the presentation of RCC
Hematuria or incidental finding
Nonspecific symptoms – fatigue, weight loss & fever
Often metastasise before local symptoms develop
If advanced:
1) Small number can secrete PTH-rP (present with hypercalcaemia)
2) Large varicocele may be present
List investigations for RCC
Radiology – ultrasound/CT scan
Endoscopy – flexible cystoscopy
Urine – cystology (looks for cancerous cells in urine, not common to do for RCC)
Describe the treatment for localised RCC
Surveillance
Increasingly small tumours removed with partial nephrectomy to preserve some renal function
Large tumours: radical nephrectomy with removal of adrenal gland, perinephric, upper ureter & para-aortic lymph nodes
Describe the treatment for metastatic RCC
Little effective treatment for metastatic disease
Palliative treatment – target angiogenesis (limit blood supply to growing tumour)
Describe the presentation of TCC
Hematuria
Incidental finding on imaging (USS or CT)
Weight loss, loss of appetite
Signs/symptoms of obstruction
Describe the causes, diagnosis & treatment of bladder TCC
Causes: analgesic misuse, exposure to aniline dyes (used in industrial manufacture) & smoking
More common in males
Can be diagnosed & treated by transurethral resection of bladder tumour (TURBT)
Describe diagnosis of bladder TCC
Investigation via cystoscopy and biopsy allows histological examination & staging
Diagnosis based on cytological examination of urine to check for the presence of malignant cells & cystoscopy of lower urinary tract
What are the differential diagnoses for TCC?
Bleeding from the prostate RCC UTI Nephritic conditions Polycystic kidney disease
Describe the treatment of bladder TCC
Low risk non-muscle invasive: treated with TURBT +/- intravesical chemotherapy to bladder
High risk non-muscle invasive: TURBT + intravesical chemotherapy, intravesical BCG treatment, cystectomy
Muscle invasive cancer – cystectomy + radiotherapy/palliative care
What is a cystectomy?
Complete removal of the bladder
Small part of the ileum (conduit) is used to act as an exit for the urine
Urine goes into stoma bag
Describe the presentation and treatment of TCC of upper urinary tract
Presentation: haematuria, obstruction occurs early because renal pelvis projects directly into the pelvicalyceal cavity
Treatment: nephron-ureterectomy (kidney, fat, ureter, cuff of bladder)
Describe carcinoma of the prostate
Risk factors: increased age, family history, ethnicity (black>white>Asian)
Lesions are most commonly found in the periphery compared with the more central location of BPH
Presentation: symptoms of UTI, prostatism or metastatic disease in the bone causing bone pain
In asymptomatic men, elevated PSA can be found which indicates carcinoma of prostate
What is prostate specific antigen?
Causes of a raised PSA – prostate cancer, infection, inflammation, large prostate & urinary retention
Having normal PSA does not mean you do not have prostate cancer and vice versa (normal PSA, but abnormal feeling prostate on DRE)